Magnostics produces high-performance Aurosphere® magnetic nanoparticles that facilitate rapid and efficient separations of proteins, nucleic acids, and cells, significantly enhancing the quality of genetic material extraction from complex samples. This technology improves the sensitivity and reproducibility of qPCR and NGS analyses, addressing challenges in liquid biopsy and miRNA detection.
Funding
Funding not disclosed
Founders
Product
Problem
Current methods for separating proteins, nucleic acids, and cells from complex samples can be inefficient and time-consuming, potentially compromising the quality of extracted genetic material. This can limit the sensitivity and reproducibility of downstream analyses such as qPCR and NGS, particularly when working with low-abundance targets.
Solution
Magnostics provides Aurosphere® magnetic nanoparticles designed to enable rapid and efficient separations of biomolecules. These high-performance nanoparticles enhance the extraction of genetic material from challenging samples like serum, nasal swabs, urine, and tissue. By improving the quality of extracted RNA or DNA, Magnostics' technology increases the sensitivity and reproducibility of downstream qPCR and NGS analyses. This leads to improved results in applications such as liquid biopsy and miRNA detection.
Target Audience
Magnostics serves the biotechnology and MedTech industries, specifically companies involved in in vitro diagnostics (IVD), bioseparations, and high throughput screening (HTS).
Features
- Aurosphere® magnetic nanoparticles for high-performance bioseparations
- Optimized for rapid and efficient separation of proteins, nucleic acids, and cells
- Nucleic acid separation technologies that improve the quality of extracted genetic material
- Extraction kits designed for use with low levels of RNA or DNA
- Products supplied to the biotechnology and MedTech industry for in vitro diagnostics (IVD), bioseparations, and high throughput screening (HTS)
- ISO13485 compliant manufacturing